Healthcare and life sciences

DLA Piper Giziński Kycia sp.k.

Client Satisfaction

Hailed by clients as a ‘premier team in the Polish market’, DLA Piper Giziński Kycia sp.k. often assists with public procurement mandates and the full spectrum of issues relating to the pricing and advertising of medicinal products. The ’outstanding’ Andrzej Balicki leads the team, and is known for his longstanding experience in both domestic and EU regulations governing pharmaceutical, diet supplement, and medical device products. Balicki is particularly adept at handling reimbursement negotiations and public procurement matters. ‘Extraordinary product lawyer’ Jolanta Dąbrowicz is a key member of the team who often assists distributors and manufacters with administrative disputes before the Main Pharmaceutical Inspectorate and the National Health Fund.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘A team with a remarkable track record in the life sciences market. I particularly appreciate their proactive approach and in-depth knowledge of industry trends.’
‘Andrzej Balicki is an outstanding lawyer in the life sciences sector with a great deal of expertise. I particularly value his deep understanding of the sector which enables him to offer strategic advice that combines legal and business aspects.’
‘DLA Piper has an outstanding team in Poland, with one of the best healthcare and life sciences lawyers on the market - Andrzej Balicki and Jolanta Dąbrowicz. They are very smart, proactive and successfully advise their clients. Portfolio of clients is also impressive.’
‘Andrzej Balicki is one of the best lawyers in this area with an amazing track record. He is definitely a go to person. Jolanta Dąbrowicz - she is a lawyer with a plenty of experience. Definitely one of the best lawyers on her level - deserves the recognition she received so far but will definitely go up.’
‘Outstanding expertise in pharma law. Attorneys understand the pharmaceutical business very well, which is a unique attribute among law firms.’
‘In my opinion, this is a premier team in the Polish market, setting a high standard for competitors. They are a highly skilled group, excelling in all key areas of industry-specific advisory services. Their grasp of both current and forthcoming life sciences regulations is exceptional.’
‘In my opinion, Andrzej Balicki is an exceptional leader. He consistently inspires his colleagues with innovative solutions and possesses a profound understanding of public policy and legislative trends. He is undoubtedly one of the leading life sciences lawyers in the market. Similarly, Jolanta Dąbrowicz stands out as an extraordinary product lawyer. Her expertise extends beyond legal matters to include a thorough understanding of the technical aspects of sector-specific regulatory requirements. Michał Orzechowski is praiseworthy for his talent in making intricate legal concepts easy to understand.’
‘The Polish DLA Piper Gizinski Kycia sp. k. team is, in my opinion, amazing. They are experts with extensive knowledge who do their job with great commitment. I can always count on them. They will always do everything to find an answer. This diverse team of outstanding experts can meet almost any challenge in a professional, efficient and effective manner. When my organisation seeks legal support, DLA Piper Polska is the first choice.’

Key clients

CMR Surgical
ExploRNA Therapeutics
Théa Polska sp. z o.o.
Smith & Nephew
Brass Research and Development
Mayoly
Philips Polska sp. z o.o.
Gemini Polska sp. z o.o.
AbbVie
ResMed
Zakłady Farmaceutyczne Polpharma
Transpharmation
Ipsen Poland
Phibro Animal Health Corporation
Polpharma
Respiromix
USP Zdrowie
Tymofarm
Vedim
Gilead Sciences
Kartos Therapeutics

Work highlights

Advised CMR Surgical on its contracting with public hospitals.
Advised a global pharmaceutical company on its collaboration with national health consultants and provincial health consultants in Poland.
Acting for ExploRNA Therapeutics in negotiations with potential partners.